LEADER 02715oas  2201081 a 450 
001 9910154525703321
005 20251106213014.0
011   $a2162-5220
035   $a(OCoLC)60616942
035   $a(CONSER)  2011200284
035   $a(CKB)111088198874356
035   $a(EXLCZ)99111088198874356
100   $a20050614a20049999  uy         a
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aDermatitis $econtact, atopic, occupational, drug
210  1$aHamilton, Ont. :$cBC Decker
210 21$aHagerstown, MD :$cWolters Kluwer Health, Inc.
210 31$aNew Rochelle, NY :$cMary Ann Liebert
215   $a1 online resource
300   $aRefereed/Peer-reviewed
311 08$a1710-3568 
531 0 $aDermatitis
606   $aContact dermatitis$vPeriodicals
606   $aDermatitis, Atopic$vPeriodicals
606   $aDermatitis, Occupational$vPeriodicals
606   $aDrug-exanthems$vPeriodicals
606   $aDermatitis, Contact
606   $aDermatitis, Atopic
606   $aDermatitis, Occupational
606   $aDrug Eruptions
606   $aDrug-exanthems$2fast$3(OCoLC)fst00898754
606   $aContact dermatitis$2fast$3(OCoLC)fst00876487
608   $aPeriodical.
608   $aPeriodicals.$2fast
615  0$aContact dermatitis
615  0$aDermatitis, Atopic
615  0$aDermatitis, Occupational
615  0$aDrug-exanthems
615 12$aDermatitis, Contact.
615 22$aDermatitis, Atopic.
615 22$aDermatitis, Occupational.
615 22$aDrug Eruptions.
615  7$aDrug-exanthems.
615  7$aContact dermatitis.
676   $a616.5
712 02$aAmerican Contact Dermatitis Society,
712 02$aNorth American Contact Dermatitis Group,
801  0$bOCLCS
801  1$bOCLCS
801  2$bMUQ
801  2$bOCLCQ
801  2$bUX1
801  2$bDLC
801  2$bPFM
801  2$bOCLCQ
801  2$bDLC
801  2$bOCLCF
801  2$bOCLCO
801  2$bOCLCQ
801  2$bNLE
801  2$bAU@
801  2$bOCLCO
801  2$bUKMGB
801  2$bVT2
801  2$bTXA
801  2$bOCLCO
801  2$bOCL
801  2$bOCLCQ
801  2$bQE2
801  2$bADU
801  2$bW2U
801  2$bHEBIS
801  2$bUAB
801  2$bLIP
801  2$bRDF
801  2$bOCLCQ
801  2$bOCLCO
801  2$bOCLCA
801  2$bQGK
801  2$bDLC
801  2$bNLM
801  2$bDLC
801  2$bOCLCQ
801  2$bOCLCL
801  2$bOCLCQ
906   $aJOURNAL
912   $a9910154525703321
996   $aDermatitis$92157066
997   $aUNINA